SCHEMBL97701

SCHEMBL97701

COP(=O)(OC)SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24860285 0.76
SCHEMBL14817305 0.76
SCHEMBL24860279 0.76
SCHEMBL11329307 0.74 MAPT (0.36)
SCHEMBL259963 0.71
SCHEMBL11642172 0.69
SCHEMBL4226333 0.69
SCHEMBL260039 0.69
Methamidophos SCHEMBL10564282 0.67
SCHEMBL600048 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 713 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035703-A1 Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping UNIV CHICAGO (US) 2026-02-05 US claimed
US-20260009033-A1 ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES UNIV CHICAGO (US) 2026-01-08 US claimed
EP-4665850-A2 OLIGONUCLEOTIDES FOR MODULATING APOLIPOPROTEIN E (APOE) EXPRESSION AND METHODS OF USE THEREOF SciNeuro Therapeutics Inc. (US) 2025-12-24 EP claimed
US-20250179495-A1 ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES UNIV CHICAGO (US) 2025-06-05 US claimed
US-20250154504-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA PROQR THERAPEUTICS II B.V. (NL) 2025-05-15 US claimed
EP-4479535-A1 GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA ProQR Therapeutics II B.V. (NL) 2024-12-25 EP claimed
US-20240327844-A1 ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES UNIV CHICAGO (US) 2024-10-03 US claimed
US-20240301428-A1 COMPOSITIONS AND METHODS FOR CORRECTING LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2C USING EXON SKIPPING UNIV CHICAGO (US) 2024-09-12 US claimed
WO-2024173439-A2 OLIGONUCLEOTIDES FOR MODULATING APOLIPROPROTEIN E (APOE) EXPRESSION AND METHODS OF USE THEREOF SCINEURO THERAPEUTICS INC. (US) 2024-08-22 WO claimed
US-20240076670-A1 ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES UNIV CHICAGO (US) 2024-03-07 US claimed
CN-101820908-A Immunostimulatory oligonucleotide analogs comprising modified sugar moieties COLEY PHARM GMBH 2010-09-01 CN claimed
CN-101517082-A CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity COLEY PHARM GMBH (DE) 2009-08-26 CN claimed
WO-2006017263-A9 TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND ITS PREPARATION THEREOF TARO PHARMA IND (IL) 2006-06-01 WO claimed
US-20060084632-A1 Topical gel formulation comprising organophosphate insecticide and its preparation thereof TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) 2006-04-20 US claimed
WO-2006017263-A1 TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND ITS PREPARATION THEREOF TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) 2006-02-16 WO claimed
CN-1688192-A Immunostimulatory nucleic acids COLEY PHARM GROUP INC (US) 2005-10-26 CN claimed
EP-1292711-B1 METHOD FOR THE HIGH-PARALLEL ANALYSIS OF POLYMORPHISMS EPIGENOMICS AG (DE) 2005-03-30 EP claimed
US-20030104464-A1 Method for the high-parallel analysis of polymorphisms EPIGENOMICS AG (DE) 2003-06-05 US claimed
CN-1315133-A Pesticide composition composed of pesticide organophosphorus compound and pesticide compound containing pyrazolyl AGREVO UK LTD (FR) 2001-10-03 CN claimed
CN-1215994-A Rnase L activators and antisense oligonucleotides effective to treat RSV infections NAT INST HEALTH (US) 1999-05-05 CN claimed